Luke Pelosi
Analyst · Raymond James
Thanks, Patrick. I’ll pick up on Page 4 of the presentation. Revenue increased over 43% compared to the prior year period. This was ahead of our July guidance and driven by outperformance across solid waste pricing, volume, commodity prices and contribution from M&A. Infrastructure organic growth turned positive for the first time since the second quarter of 2020. And liquid waste benefited from the Terrapure acquisition effectively closing 2 months earlier than anticipated. Similar to our comments on the recovery of solid waste volumes in Canada, we expect improving strength in the recovery of both of these segments as restrictions in Canada continue to ease. On Page 5, you’ll see adjusted EBITDA for Q3 of $415.8 million at a margin of 28%, an increase of 90 basis points over the prior period and up 110 basis points sequentially over Q2. We’re particularly pleased with this result when considering the backdrop of rising labor and input cost inflation as well as the reintroduction of certain discretionary costs such as travel and entertainment, incentive compensation and certain professional fees that were all a headwind to margin. Solid waste margins of 31.7% were 110 basis points ahead of the prior comparable period and 80 basis points up sequentially over Q2. 100 basis points of the margin expansion was organic and driven by our pricing programs and operating leverage and volume recovery. Commodity pricing was a 90 basis point tailwind, but this was substantially offset by a 70 basis point drag from fuel prices and a 10 basis point headwind from M&A. Liquid waste margins increased 50 basis points sequentially over Q2 and nearly 300 basis points organically over the prior year period before considering the margin dilutive impact of the contribution from Terrapure in the quarter. Over 85% of Terrapure revenue is currently reported in our liquid waste segment with allocations between the segments to be revised in 2022. Terrapure’s liquid waste revenue came in just below mid-20s margin, but we continue to see a path to bring that up to the segment average. Infrastructure and soil margins improved 190 basis points sequentially from Q2 and 90 basis points period-over-period as volumes turn positive, and we’re able to leverage the relatively fixed cost structure of the segment. On Page 6, you can see adjusted cash flow from operating activities of $250 million, inclusive of $95 million of proceeds from our asset sale. Once again, we’re including these excess proceeds in our adjusted free cash flow rec as we intend to redeploy most of these dollars before the end of the year. And therefore, these proceeds or a portion thereof will be used to offset the over and above growth capital we expect to deploy before year-end. While there will be some lumpiness from quarter-to-quarter, the annual free cash flow reconciliation will include a normalized level of capital expenditures for the business. During the quarter, we’ve normalized for $35 million of working capital related to recent M&A, which we believe is better characterized as part of the purchase price. Note that an inaugural holiday in Canada on September 30 impacted working capital by approximately $15 million as compared to the prior year. Turning to Page 7. As previously announced, we were once again successful in accessing the debt capital markets to raise capital at attractive coupons and amended our credit facility to, among other things, tighten the borrowing rate by 50 basis points, all consistent with our strategy of leveraging our ever-improving credit quality to drive the lower cost of debt. During the quarter, we deployed approximately $1.1 billion into 14 acquisitions. And post quarter end, we deployed an incremental $900 million for another 8 acquisitions. Net of the contribution of one business sold as part of a divestiture, we expect to generate annualized revenues of approximately $735 million from these acquisitions. We anticipate approximately $450 million of this rolling over into 2022, and this amount would further increase to the extent there’s any incremental M&A completed before the end of the year. As anticipated, net leverage at quarter end modestly stepped up with the acquisition of Terrapure. The cash on hand at quarter end was largely used to fund the M&A in October, and we continue to have ample liquidity to support our growth goals. Additionally, during the quarter, we entered a definitive agreement, which gives us the right to issue up to an aggregate amount of USD 300 million of preferred shares before the end of the year. We will draw on this equity commitment as needed to allow us to continue executing our growth strategy while maintaining our previously stated leverage targets. On Page 8, we’re showing the drivers of our updated guidance. For the year, we’re now expecting revenue of $5.4 billion, a $150 million increase over the guidance we provided in July when measuring midpoint to midpoint. The components are laid out on the page, but the growth comes from price, volume and M&A contribution, all exceeding our previously communicated expectations. For the year, we’re now expecting pricing at 4.25 and volume in the mid-2s, both about 25 basis points higher than our July guidance and an encouraging launch-off point for 2022. From this revenue, we expect adjusted EBITDA of $1,440 million to $1,450 million, a $37.5 million increase over July’s guidance, again, measured midpoint to midpoint. In terms of CapEx, recall the guide at the beginning of the year was a base CapEx of $510 million. With the first half growth of the business, we increased this to $525 million in July and are now increasing to $540 million, in line with the outsized growth of the business. On top of this number, we guided on the opportunity to redeploy proceeds from asset disposals into attractive growth opportunities. Our original guidance for this opportunity was $50 million to $100 million of incremental spend. As of today, we think we’ll be at the high end or more of this range, a terrific outcome as this investment will drive high-quality incremental growth in 2022. Now all of this incremental spend was being covered by the proceeds from asset disposals. So although there would be a gross CapEx number of $640 million, the $540 million plus $100 million, the net CapEx would remain at $540 million. We have been extremely successful in our portfolio rationalization program, realizing $170 million of proceeds to date from asset disposals and asset divestitures with the possibility to realize more before the year is done. Including 100% of these proceeds in our year-end adjusted free cash flow reconciliation would yield a net CapEx number of $470 million and effectively overstate our free cash flow for the year. So at year-end, we will include an adjustment to exclude excess proceeds from disposal and normalize the net CapEx number to somewhere around $540 million. On working capital, the new guide has us going to a use of approximately $35 million to $40 million as compared to nil in the original July guide. This is over and above the M&A-related working capital investment. And all of this yields an adjusted free cash flow of $525 million to $530 million, a $10 million to $15 million increase over July’s guide despite the incremental $50 million investment in CapEx and working capital. We’re not going to specifically walk through Q4, but you can do the math and see the implied results at the midpoint is approximately $1.415 billion of revenue, a 26.1% adjusted EBITDA margin, a 90 basis point increase over the prior year. This is based on pricing of low 4s and volume of 0.5 point to 1 point, both above our July guidance. From a modeling perspective, I think many continue to underestimate the expensive seasonality in the business. And therefore, there’s a recalibration of dollars between Q3 and Q4. For Q4 implied free cash flow, the normalized CapEx dynamic I just spoke to complicates the simple full year less year-to-date math. The Q3 year-to-date adjusted free cash flow number of $512 million is inclusive of excess proceeds from disposal. Excluding $70 million of these proceeds from the $512 million and then bridge into the full year number will give a better picture of Q4 on a stand-alone basis. And lastly, while not going -- while we’re not going to provide our guidance for 2022 until we meet again in February, where we’re already sitting with nearly 8.5% top line growth from rollover, and we anticipate the constructive macro backdrop to support organic price and volume of better than 6. So as Patrick mentioned, there’s a clear path to 15% plus top line growth before considering anything incremental to what we have today. With that, I will turn the call back over to Patrick.